GigaGen Publishes Research Showcasing First-Ever Clinical GMP Manufacturing and IND-Enabling Studies for its New Class of Drugs, Recombinant Polyclonal AntibodiesGlobeNewsWire • 07/28/22
Got $20? These 3 Healthcare Stocks Could Be Bargain Buys for 2022 and BeyondThe Motley Fool • 05/26/22
GigaGen Publishes Research Demonstrating the Potential of its Machine Learning Platform to Improve Antibody Drug Discovery and DevelopmentGlobeNewsWire • 05/19/22
Grifols completes the acquisition of Biotest: a strategic and transformational transaction to accelerate growth and innovationPRNewsWire • 04/25/22
Grifols signs global collaboration and licensing agreement with Endpoint Health to develop and commercialize Antithrombin III for SepsisPRNewsWire • 02/24/22
Grifols PharmacyKeeper ranked No. 1 as 'Best in KLAS,' extends category leadership for sixth consecutive yearPRNewsWire • 02/09/22
Grifols reaches milestone with 300th U.S. plasma donor center, continuing to increase supply of urgently needed plasmaPRNewsWire • 11/30/21
Grifols introduces ALBUTEIN FlexBag™ (Albumin [Human] U.S.P.) in 5% and 25% concentrations, a more convenient option for healthcare professionalsPRNewsWire • 11/04/21
Grifols and Egypt inaugurate first African plasma-supply platform, in Cairo, as part of the alliance to attain self-sufficiency in plasma-derived medicinesPRNewsWire • 10/19/21
Pharma deal: Biotest up 12% after Grifols to pay $1.3 billion for majority stakeMarket Watch • 09/17/21
Grifols: Valuation Discount Remains Wide Despite An Upbeat Capital Markets DaySeeking Alpha • 07/02/21
Grifols introduces HyperHEP B® (hepatitis B immune globulin [human]), a new formulation to treat patients exposed to hepatitis BPRNewsWire • 06/01/21
Grifols takes another step in the fight against Alzheimer's, partners with Ace to open first AMBAR® Center in BarcelonaPRNewsWire • 05/19/21
Grifols and Andorran government will establish world-class immunology research hub to expand global knowledge of the immune system and develop therapeuticsPRNewsWire • 04/28/21
Grifols Extends Commitment to World Federation of Hemophilia Humanitarian Aid Program to 2030PRNewsWire • 04/15/21